NORGES BANK - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORGES BANK ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$65,410,322
+257.4%
960,504
+67.7%
0.02%
+240.0%
Q2 2022$18,300,800
-0.2%
572,795
+8.2%
0.01%
+25.0%
Q1 2022$18,344,998
+210.1%
529,590
+162.0%
0.00%
+300.0%
Q4 2021$5,916,000
-36.9%
202,121
-45.0%
0.00%
-50.0%
Q3 2021$9,371,000
-27.2%
367,7780.0%0.00%
-33.3%
Q2 2021$12,880,000
-29.4%
367,778
-17.9%
0.00%
-25.0%
Q1 2021$18,245,000
-24.0%
447,726
-19.2%
0.00%
-33.3%
Q4 2020$24,006,000
-20.9%
554,284
+0.7%
0.01%
-25.0%
Q3 2020$30,357,000
-11.4%
550,540
+1.4%
0.01%
-20.0%
Q2 2020$34,281,000
+5.0%
543,023
-15.0%
0.01%
-16.7%
Q1 2020$32,651,000
-35.7%
639,0820.0%0.01%
-14.3%
Q4 2019$50,801,000
+67.3%
639,082
+2.1%
0.01%
+55.6%
Q3 2019$30,368,000
-7.8%
625,8920.0%0.01%
-10.0%
Q2 2019$32,922,000
+13.3%
625,892
+14.0%
0.01%
+11.1%
Q1 2019$29,056,000
+63.0%
548,949
+26.4%
0.01%
+28.6%
Q4 2018$17,826,000
+79.2%
434,259
+65.9%
0.01%
+133.3%
Q3 2018$9,945,000
-15.9%
261,6950.0%0.00%
-25.0%
Q2 2018$11,829,000
-2.3%
261,695
+4.4%
0.00%0.0%
Q1 2018$12,104,000
+1031.2%
250,608
+415.7%
0.00%
+300.0%
Q3 2016$1,070,000
+7.5%
48,600
-19.0%
0.00%
Q2 2016$995,00060,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders